Table 3.
Sample | Compound | Dose, 10 mg/kg
|
Dose, 5 mg/kg
|
||
---|---|---|---|---|---|
Wild type | mdr1a(−/−) | Wild type | mdr1a(−/−) | ||
Plasma (level, ng/ml) | Paclitaxel | 2020 ± 420 | 2370 ± 280 | 289 ± 38 | 327 ± 44 |
Bile | Paclitaxel | 4.81 ± 0.27 | 2.56 ± 0.58 | 5.94 ± 1.70 | 4.10 ± 0.54 |
3′-p-hydroxypaclitaxel | 2.86 ± 0.28 | 2.48 ± 0.26 | 4.74 ± 0.69 | 4.10 ± 0.18 | |
6α-hydroxypaclitaxel | 2.00 ± 0.25 | 1.29 ± 0.24 | 3.25 ± 0.51 | 1.98 ± 0.22 | |
3H label | 17.9 ± 0.69 | 15.0 ± 1.5 | 25.7 ± 4.5 | 26.6 ± 2.90 | |
Intestinal contents | Paclitaxel | 10.77 ± 0.25 | 2.49 ± 0.86* | 3.53 ± 0.38 | 0.98 ± 0.28* |
3-p-hydroxypaclitaxel† | |||||
6α-hydroxypaclitaxel | 0.37 ± 0.10 | 0.37 ± 0.16 | 0.16 ± 0.05 | <0.1 | |
3H label | 12.22 ± 0.28 | 3.79 ± 1.11* | 4.63 ± 0.49 | 1.52 ± 0.05 |
Excretion is given as percentage of the dose (mean ± SEM; n = 4). ND, Not detectable.
P < 0.05.
This compound could not be accurately quantified in the intestinal contents due to the presence of an interfering substance.